DSP Group Inc.’s First Quarter 2017 Earnings Release and Conference Call
Apr 10, 2017 11:02 am UTC| Business
LOS ALTOS, Calif., April 10, 2017 -- DSP Group® Inc. (NASDAQ:DSPG), will release its earnings results for the first quarter of 2017 on April 27th, 2017 before market opens. The company would like to invite you to...
DSP Group Inc.’s First Quarter 2017 Earnings Release and Conference Call
Apr 10, 2017 11:02 am UTC| Business
LOS ALTOS, Calif., April 10, 2017 -- DSP Group® Inc. (NASDAQ:DSPG), will release its earnings results for the first quarter of 2017 on April 27th, 2017 before market opens. The company would like to invite you to...
NeuroDerm to Host Investor Day on April 21, 2017
Apr 10, 2017 11:01 am UTC| Business
REHOVOT, Israel, April 10, 2017 -- NeuroDerm Ltd. (Nasdaq:NDRM), a clinical stage pharmaceutical company developing drug-device combinations for central nervous system (CNS) disorders, today announced that the Company...
NeuroDerm to Host Investor Day on April 21, 2017
Apr 10, 2017 11:01 am UTC| Business
REHOVOT, Israel, April 10, 2017 -- NeuroDerm Ltd. (Nasdaq:NDRM), a clinical stage pharmaceutical company developing drug-device combinations for central nervous system (CNS) disorders, today announced that the Company...
Apr 10, 2017 11:01 am UTC| Business
SAN DIEGO, April 10, 2017 -- Kratos Defense Security Solutions, Inc. (NASDAQ:KTOS), a leading National Security Solutions provider, announced today that Kratos' Defense Rocket Support Services (DRSS) Division...
Apr 10, 2017 11:01 am UTC| Business
SAN DIEGO, April 10, 2017 -- Kratos Defense Security Solutions, Inc. (NASDAQ:KTOS), a leading National Security Solutions provider, announced today that Kratos' Defense Rocket Support Services (DRSS) Division...
Cytori Receives U.S. FDA Approval for Burn Clinical Trial Related to BARDA Contract
Apr 10, 2017 11:01 am UTC| Business
SAN DIEGO, April 10, 2017 -- Cytori Therapeutics, Inc. (NASDAQ:CYTX) today announced that the U.S. Food and Drug Administration (FDA) has approved an Investigational Device Exemption (IDE) for a pilot clinical trial to...